•
Sep 30, 2023

Sabra Health Care REIT Q3 2023 Earnings Report

Sabra's Q3 2023 results reflected a business moving away from pandemic impacts, with improvements in occupancy and rent coverage, particularly in the senior housing managed portfolio.

Key Takeaways

Sabra Health Care REIT reported a net loss of $(0.07) per diluted common share for Q3 2023. However, the company saw strong improvement in its senior housing managed portfolio and an increase in occupancy. Sabra generated $80 million from the disposition of 13 skilled nursing and two senior housing facilities, and liquidity as of September 30, 2023, was approximately $1.0 billion.

Net loss was $(0.07) per diluted common share.

FFO was $0.33 per share, and Normalized FFO was $0.33 per share.

AFFO was $0.35 per share, and Normalized AFFO was $0.34 per share.

Senior housing managed portfolio showed strong improvement in critical metrics.

Total Revenue
$163M
Previous year: $141M
+15.8%
EPS
$0.33
Previous year: $0.36
-8.3%
FFO per diluted share
$0.33
Previous year: $0.28
+17.9%
Normalized FFO per diluted share
$0.33
Previous year: $0.36
-8.3%
AFFO per diluted share
$0.35
Previous year: $0.34
+2.9%
Gross Profit
$113M
Previous year: $98.9M
+14.0%
Cash and Equivalents
$33.3M
Previous year: $26.3M
+26.5%
Free Cash Flow
$83.2M
Total Assets
$5.38B
Previous year: $5.84B
-7.9%

Sabra Health Care REIT

Sabra Health Care REIT

Sabra Health Care REIT Revenue by Segment

Sabra Health Care REIT Revenue by Geographic Location

Forward Guidance

Sabra did not provide forward guidance in the Q3 2023 earnings report.